JBS N.V. has made a significant move by acquiring Flora Produtos de Higiene e Limpeza S.A. for $542 million. This acquisition marks JBS's entry into the personal care market, expanding its consumer products platform and creating new growth opportunities in nutrition, health, and beauty.

The acquisition is expected to strengthen JBS's existing capabilities in ingredients and collagen, allowing the company to connect its expertise with Flora's consumer products and distribution network. Flora, a leading Brazilian company in bath and laundry care products, generated annual net revenue of R$2.9 billion (approximately $531 million) for the twelve months ending September 2026.

According to JBS, the acquisition will be financed through the issuance of Class A common shares and/or Brazilian depositary receipts (BDRs), with an equity consideration of $367 million. The structure of the deal is designed to maintain JBS's financial discipline while expanding its consumer products platform.

In addition to the Flora acquisition, JBS also announced the purchase of Canal Rural Produções Ltda., a media company focused on agribusiness, for $11 million. This acquisition will further enhance JBS's presence in the agricultural sector.

Both acquisitions are expected to close in December 2026, pending customary closing conditions. These strategic moves reflect JBS's commitment to diversifying its portfolio and tapping into the growing global wellness market, which is valued at $2.7 trillion.

JBS's long-standing relationship with Flora dates back to when Flora was part of JBS's hygiene and cleaning products division before being separated in 2007. The acquisition is anticipated to strengthen this relationship and create additional value from animal protein coproducts.

As JBS continues to expand its footprint in the consumer products sector, it aims to leverage its innovation capabilities through its biotech divisions in Brazil and Spain, opening new avenues for developing functional ingredients in health and beauty.

Details regarding the financial implications of these acquisitions were outlined in JBS's recent SEC filing, accession number 0001213900-26-117580.